Additionally, this study pinpoints LAYN as a potential immune checkpoint showing the most significant correlation with SRRS, sparking further inquiry into the function of LAYN in CRC and its potential as a therapeutic target (64). The gene discussed is LAYN; the disease is colorectal carcinoma.